Persistent Basal Cell Hyperplasia Is Associated With Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis
- PMID: 31499251
- PMCID: PMC7058491
- DOI: 10.1016/j.cgh.2019.08.055
Persistent Basal Cell Hyperplasia Is Associated With Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis
Abstract
Background & aims: Although eosinophil count is the standard used to monitor disease activity in patients with eosinophilic esophagitis (EoE), there are often disparities between patient-reported symptoms and eosinophil counts. We examined the prevalence of epithelial alterations, namely basal cell hyperplasia (BCH) and spongiosis, among patients with inactive EoE (eosinophil counts below 15 following therapy) and aimed to determine whether maintenance of these changes in epithelial morphology are associated with persistent clinical findings.
Methods: Esophageal biopsies of 243 patients (mean age, 16.9 years) undergoing routine endoscopy at the University of Pennsylvania were evaluated for epithelial BCH and spongiosis. Univariable analysis was used to calculate the association between epithelial changes and symptoms as well as endoscopic findings and peak eosinophil count. We validated our findings using data from a cohort of patients at the University of North Carolina.
Results: The discovery and validation cohorts each included patients with inactive EoE, based on histologic factors, but ongoing BCH and spongiosis. Ongoing BCH, but not spongiosis, in patients with inactive EoE was associated with symptoms (odds ratio, 2.14; 95% CI, 1.03-4.42; P = .041) and endoscopic findings (odds ratio, 7.10; 95% CI, 3.12-16.18; P < .001).
Conclusions: In patients with EoE, the presence of BCH might indicate ongoing disease activity, independent of eosinophil count. This might account for the persistent symptoms in patients who are considered to be in remission based on histologic factors.
Keywords: Epithelium; Esophagus; Inflammation; Outcome; Prognostic Factor.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures

References
-
- Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128:3-20.e6; quiz 21–2. - PubMed
-
- Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology 2013;145:1230–6 e1–2. - PubMed
-
- Collins MH. Histopathologic features of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008;18:59–71; viii-ix. - PubMed
-
- Katzka DA, Ravi K, Geno DM, et al. Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol 2015;13:1242–1248.e1. - PubMed
Publication types
MeSH terms
Grants and funding
- K01 DK103953/DK/NIDDK NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- R03 DK118310/DK/NIDDK NIH HHS/United States
- K23 DK090073/DK/NIDDK NIH HHS/United States
- R03 DK118304/DK/NIDDK NIH HHS/United States
- U54 AI117804/AI/NIAID NIH HHS/United States
- K08 DK106444/DK/NIDDK NIH HHS/United States
- T32 DK007066/DK/NIDDK NIH HHS/United States
- R01 AA026297/AA/NIAAA NIH HHS/United States
- K08 DK099379/DK/NIDDK NIH HHS/United States
- R01 DK121159/DK/NIDDK NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- KL2 TR001879/TR/NCATS NIH HHS/United States
- P30 DK050306/DK/NIDDK NIH HHS/United States
- R01 DK114436/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical